155 related articles for article (PubMed ID: 23967426)
1. Descriptive Aspects of Injection Drug Users in Iran's National Harm Reduction Program by Methadone Maintenance Treatment.
Eskandarieh S; Nikfarjam A; Tarjoman T; Nasehi A; Jafari F; Saberi-Zafarghandi MB
Iran J Public Health; 2013; 42(6):588-93. PubMed ID: 23967426
[TBL] [Abstract][Full Text] [Related]
2. Compulsory maintenance treatment program amongst Iranian injection drug users and its side effects.
Eskandarieh S; Jafari F; Yazdani S; Hazrati N; Saberi-Zafarghandi MB
Int J High Risk Behav Addict; 2014 Dec; 3(4):e21765. PubMed ID: 25741482
[TBL] [Abstract][Full Text] [Related]
3. Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran.
Razzaghi EM; Movaghar AR; Green TC; Khoshnood K
Harm Reduct J; 2006 Mar; 3():12. PubMed ID: 16545137
[TBL] [Abstract][Full Text] [Related]
4. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?
Ekhtiari H; Noroozi A; Farhoudian A; Radfar SR; Hajebi A; Sefatian S; Zare-Bidoky M; Razaghi EM; Mokri A; Rahimi-Movaghar A; Rawson R
Addiction; 2020 Jul; 115(7):1395-1403. PubMed ID: 31737965
[TBL] [Abstract][Full Text] [Related]
5. Methadone maintenance therapy outcomes in Iran.
Noori R; Narenjiha H; Aghabakhshi H; Habibi G; Khoshkrood Mansoori B
Subst Use Misuse; 2012 Jun; 47(7):767-73. PubMed ID: 22416897
[TBL] [Abstract][Full Text] [Related]
6. Drug use and HIV/AIDS in China.
Liu Z; Lian Z; Zhao C
Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users.
Alavian SM; Mirahmadizadeh A; Javanbakht M; Keshtkaran A; Heidari A; Mashayekhi A; Salimi S; Hadian M
Hepat Mon; 2013; 13(8):e12411. PubMed ID: 24069039
[TBL] [Abstract][Full Text] [Related]
8. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
9. DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China.
Zhang JY; Li ZB; Zhang L; Wang J; Huang LP; Zhan GL; Li Z; Du J; Zhao M
BMC Infect Dis; 2019 Sep; 19(1):774. PubMed ID: 31488064
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.
Alistar SS; Owens DK; Brandeau ML
PLoS Med; 2011 Mar; 8(3):e1000423. PubMed ID: 21390264
[TBL] [Abstract][Full Text] [Related]
12. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.
Moradi G; Farnia M; Shokoohi M; Shahbazi M; Moazen B; Rahmani K
Int J Health Policy Manag; 2015 Mar; 4(9):583-9. PubMed ID: 26340487
[TBL] [Abstract][Full Text] [Related]
13. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
Emmanuelli J; Desenclos JC
Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
[TBL] [Abstract][Full Text] [Related]
14. [A cross-sectional survey of receiving no methadone maintenance treatment in HIV infected injecting drug users in Dehong Dai and Jingpo autonomous prefecture, Yunnan province].
Tang RH; Ye RH; Yang YC; Yao ST; Wang JB; Zhang RM; Luo LF; Wu ZL; Long YC; Yin MS; He N; Duan S
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Mar; 38(3):336-340. PubMed ID: 28329935
[No Abstract] [Full Text] [Related]
15. [Overdose of heroin and influencing factors in intravenous drug users in parts of Yunnan].
Zhou Y; Luo W; Cao XB; Zhang B; Wu ZY
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):648-52. PubMed ID: 27188355
[TBL] [Abstract][Full Text] [Related]
16. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
Liu Y; Liu Y; Zou X; Chen W; Ling L
BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
[TBL] [Abstract][Full Text] [Related]
17. Substance Abuse and the HIV Situation in Malaysia.
Singh D; Chawarski MC; Schottenfeld R; Vicknasingam B
J Food Drug Anal; 2013 Dec; 21(4):S46-S51. PubMed ID: 25278737
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Drug Use and Related Factors Among Prisoners in Iran: Results from the National Survey in 2015.
Moradi G; Darvishi S; Asaadi L; Azimian Zavareh F; Gouya MM; Tashakorian M; Alasvand R; Mohamadi Bolbanabad A
J Prim Prev; 2020 Feb; 41(1):29-38. PubMed ID: 31912408
[TBL] [Abstract][Full Text] [Related]
19. Carriage of Staphylococcus aureus among injection drug users: lower prevalence in an injection heroin maintenance program than in an oral methadone program.
Bassetti S; Wolfisberg L; Jaussi B; Frei R; Kuntze MF; Battegay M; Widmer AF
Infect Control Hosp Epidemiol; 2004 Feb; 25(2):133-7. PubMed ID: 14994939
[TBL] [Abstract][Full Text] [Related]
20. The long-term effectiveness of methadone maintenance treatment in prevention of hepatitis C virus among illicit drug users: a modeling study.
Javanbakht M; Mirahmadizadeh A; Mashayekhi A
Iran Red Crescent Med J; 2014 Feb; 16(2):e13484. PubMed ID: 24719731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
